Your browser doesn't support javascript.
loading
Phase Ib study of combinations of avadomide (CC-122), CC-223, CC-292, and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma.
Ribrag, Vincent; Chavez, Julio C; Boccomini, Carola; Kaplan, Jason; Chandler, Jason C; Santoro, Armando; Corradini, Paolo; Flinn, Ian W; Advani, Ranjana; Cassier, Philippe A; Sangha, Randeep; Kenkre, Vaishalee P; Isufi, Iris; Uttamsingh, Shailaja; Hagner, Patrick R; Gandhi, Anita K; Shen, Frank; Michelliza, Sophie; Haeske, Harald; Hege, Kristen; Pourdehnad, Michael; Kuruvilla, John.
Affiliation
  • Ribrag V; Institut Gustave Roussy Villejuif France.
  • Chavez JC; H. Lee Moffitt Cancer Center & Research Institute Tampa Florida USA.
  • Boccomini C; Candiolo Cancer Institute FPO-IRCCS Turin Italy.
  • Kaplan J; Feinberg School of Medicine Northwestern University Chicago Illinois USA.
  • Chandler JC; West Cancer Center Memphis Tennessee USA.
  • Santoro A; Humanitas Clinical and Research Center IRCCS Humanitas University Rozzano-Milano Italy.
  • Corradini P; IRCCS Istituto Nazionale dei Tumori University of Milano Milano Italy.
  • Flinn IW; Sarah Cannon Research Institute Nashville Tennessee USA.
  • Advani R; Stanford Cancer Institute Stanford California USA.
  • Cassier PA; Centre Leon Berard Lyon France.
  • Sangha R; Cross Cancer Institute Edmonton Canada.
  • Kenkre VP; Division of Hematology/Oncology University of Wisconsin Madison Wisconsin USA.
  • Isufi I; Yale Cancer Center New Haven Connecticut USA.
  • Uttamsingh S; Bristol Myers Squibb Princeton New Jersey USA.
  • Hagner PR; Bristol Myers Squibb Princeton New Jersey USA.
  • Gandhi AK; Bristol Myers Squibb Princeton New Jersey USA.
  • Shen F; Bristol Myers Squibb Princeton New Jersey USA.
  • Michelliza S; Bristol Myers Squibb Princeton New Jersey USA.
  • Haeske H; Bristol Myers Squibb Princeton New Jersey USA.
  • Hege K; Bristol Myers Squibb Princeton New Jersey USA.
  • Pourdehnad M; Bristol Myers Squibb Princeton New Jersey USA.
  • Kuruvilla J; Division of Medical Oncology and Hematology Princess Margaret Cancer Centre University of Toronto Toronto Canada.
EJHaem ; 3(1): 139-153, 2022 Feb.
Article in En | MEDLINE | ID: mdl-35846221
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: EJHaem Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: EJHaem Year: 2022 Document type: Article